<DOC>
	<DOCNO>NCT02049918</DOCNO>
	<brief_summary>Collect de-identified , residual sample support clinical trial . Samples may prospectively retrospectively collect . Overall Study Objective Obtain clinical performance data characterize clinical performance Respiratory Viral Panel GenMark Sample-to-Answer Platform .</brief_summary>
	<brief_title>Residual Sample Collection Respiratory Viral Panel</brief_title>
	<detailed_description>The purpose investigational study collect clinical sample establish clinical performance characteristic vitro diagnostic ( IVD ) Respiratory Viral Panel GenMark Sample-to-Answer Platform . Data obtain sample use support premarket submissions/registrations GenMark product . Samples aliquotted , characterize comparator method bank instrument assay available testing . Sample collection may prospective retrospective . Prospective collection preserve prevalence . Retrospective collection use obtain sufficient number certain sample type organism interest low prevalence . The Sponsor ensure information identify sample prospectively retrospectively collect document .</detailed_description>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>Sample patient exhibit signs/symptoms respiratory viral infection All medical standardofcare test request submit clinician complete report clinician/requestor . Samples incorrectly deidentified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Respiratory virus</keyword>
</DOC>